Search Results
Dec 17, 2025, 19:00 ET Nature | Two Phase 3 Clinical Results of Mazdutide (GLP-1/GCG Dual Receptor Agonist) in Chinese Adults with Type 2 Diabetes Have Been Back-to-Back Published in Nature
participants with T2D.DREAMS-2: A Phase 3 trial comparing mazdutide and dulaglutide in Chinese T2D participants with inadequate glycemic control on oral antidiabetic drugs.DREAMS-3: A Phase 3 trial comparing mazdutide and semaglutide in Chinese participants with T2D and obesity.GLORY-3:
More news about: Innovent Biologics
Dec 17, 2025, 18:49 ET U.S. FDA Approval of RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) Enables the Simplest, Shortest Administration Time for a First-Line Combination Regimen when Combined with LAZCLUZE® (lazertinib)
LAZCLUZE® (marketed as LECLAZA in South Korea). LAZCLUZE® is an oral, third-generation, brain-penetrant EGFR TKI that targets both the T790M mutation and activating EGFR mutations while sparing wild-type EGFR. An analysis of the efficacy and safety of LAZCLUZE® from the Phase
More news about: Johnson & Johnson
Dec 17, 2025, 18:33 ET INTEGRA DELIVERS ROBUST FEASIBILITY STUDY FOR DELAMAR GOLD-SILVER HEAP LEACH PROJECT HIGHLIGHTING IMPROVED ECONOMICS AND REDUCED DEVELOPMENT RISK
finish on a 1 assay ton aliquot. Gold results over 5 g/t are re-run using a gravimetric finish. Silver analysis is performed using ICP for results up to 100 g/t on a 5-acid digestion, with a fire assay, gravimetric finish for results over 100 g/t silver.Additional supporting details regarding the
More news about: Integra Resources Corp.
Dec 17, 2025, 16:38 ET Clywedog Therapeutics Announces Activation of All Centers and Patient Dosing in Multicenter, International Phase 1b Clinical Study of Balomenib in Type 2 Diabetes
randomized, double-blind, placebo-controlled clinical study evaluating balomenib, a novel oral menin inhibitor, in adults with type 2 diabetes mellitus (T2DM). The study received formal regulatory authorization in September and is expected to enroll up to 60 participants."This milestone marks
More news about: Clywedog Therapeutics, Inc.
Dec 17, 2025, 16:05 ET Global Expert Panel Publishes New Recommendations on Advanced Use of Closed Incision Negative Pressure Therapy
developments._________________________________1 Solventum Prevena™ Therapy is the only ciNPT dressing that uses ROCF.2 Singh D, Alton T, Alvand A, et al. Linear and Area Coverage with Closed Incision Negative Pressure Therapy Management: International Multidisciplinary Consensus
More news about: Solventum
Dec 17, 2025, 15:00 ET LG SIGNATURE evolui com IA e redefine o conceito de eletrodomésticos premium na CES 2026
receitas e oferecer substituições criativas com base nos itens armazenados². Quando a tela não está em uso, é possível exibir imagens elegantes no painel T-OLED InstaView da porta da geladeira, enriquecendo o ambiente e transformando a cozinha em um espaço expressivo e inspirador.Para aprimorar a experiência
More news about: LG Electronics Brasil
Dec 17, 2025, 11:55 ET The Race for Resources: $4,300 Gold Triggers Aggressive Global Drilling Frenzy
Diamba Sud Gold Project in Senegal, with drill hole DSDD574 intersecting 1.7 g/t gold over 29.6 meters and a further 2.0 g/t gold over 20.0 meters. Infill drilling returned 6.8 g/t gold over 35.5 meters in hole DSDD555 and 13.54 g/t gold over 13.3 meters in hole 145W."Southern Arc continues to deliver
More news about: USA News Group
Dec 17, 2025, 11:30 ET The John Wayne Friday Night Feature Returns to FMC in 2026
in 2021, FMC features a 24-hour schedule celebrating the depth and variety of classic movies and is currently available on DIRECTV, DIRECTV Stream, AT&T U-verse, DISH, Xfinity, Fubo, Frndly, Philo, and altafiber. FETV and FMC are independently owned and operated by Family Broadcasting Company based
More news about: FMC (Family Movie Classics)
Dec 17, 2025, 11:00 ET Nationally Renowned Anesthesiology Physician-Scientist and Clinical Operations Leader David Mintz, MD, PhD, Named Chair of the Department of Anesthesiology at the UM School of Medicine
the Hopkins T32 Postdoctoral Research Fellowship Program, fostering research training for future physician-scientists."Dr. Mintz is the ultimate 'triple threat' in academic medicine. He is an exceptional clinician, NIH RO1 funded neuroscientist, and educator who directs a successful T32 physician-scientist
More news about: University of Maryland Medical Center
Dec 17, 2025, 11:00 ET Breast Cancer Drugs Market to Reach USD 57.1 Billion by 2031 as Precision Oncology and Targeted Therapies Redefine Treatment Outcomes
APAC.F. Hoffmann-La Roche Ltd.Key Breast Cancer Products: Herceptin (trastuzumab), Perjeta (pertuzumab), Kadcyla (T-DM1), Phesgo (SC pertuzumab/trastuzumab), Tecentriq (atezolizumab)Core strengths: Global benchmark in HER2-targeted therapy
More news about: DataM Intelligence 4 Market Research LLP
Dec 17, 2025, 10:04 ET Ambition Introduces New AI Assistant to Transform Coaching for Managers and Sales Leaders
reps ramp more quickly, and sales leaders have full clarity on potential risks and opportunities. Trusted by world-class companies like Zoom and T-Mobile, Ambition empowers frontline managers to activate a high-performance sales culture that drives predictable revenue growth. Learn more at
More news about: Ambition
Dec 17, 2025, 09:30 ET Vitalis Ventures Announces $15 Million Strategic Funding for Drive Health to Accelerate Avery, the Clinical Workflow AI
in underserved communities. The initiative will support more than 56,000 participating families with Google Pixel devices, Fitbit technology, and AT&T connectivity, while Avery delivers clinician-approved education, appointment reminders, and structured symptom check-ins from pregnancy through postpartum
More news about: Vitalis
Dec 17, 2025, 09:14 ET My Better Batch Closes Out 2025 With Strong Retail Growth, Emerging as a Company to Watch in 2026
mybetterbatch.com.Media Contact:T-Aira [email protected]
More news about: My Better Batch
Dec 17, 2025, 08:33 ET Kerrville Honors Sewa International, Partner Organizations for Flood Relief and Recovery Efforts
Charity Foundation Houston (IACF) shared their guiding principle: "We live here, we give here.""It was impossible to miss the sea of yellow T-shirts," a city representative recalled, Sewa International volunteers who managed traffic, coordinated logistics, and organized hundreds of community volunteers
More news about: Sewa International
Dec 17, 2025, 08:01 ET Nona Biosciences and Valink Therapeutics Form Strategic Alliance to Accelerate Novel Biologics Discovery
applications using fully human VH single-domain antibodies as a plug-and-play system, including bispecific antibodies, multi-specific antibodies, CAR-T therapies, antibody-drug conjugates (ADCs), mRNA-based therapeutics, and more.By integrating Harbour Mice®, single-B cell screening
More news about: Nona Biosciences
Dec 17, 2025, 08:00 ET Eagle Electronics acquires Wireless Mobility, combined company rebrands as Eagle Wireless
module partner across product needs and have confidence in a partner that is aligned with U.S. and allied Western regulatory requirements."AT&T Connected Solutions is committed to delivering secure, scalable connectivity for automotive and IoT customers. Eagle Wireless' commitment to domestic
More news about: Eagle Electronics
Dec 17, 2025, 08:00 ET Achieve and Pagaya Launch Partnership to Expand Access to Personal Loans
first personal loan platforms to adopt FICO® Score 10 T, which incorporates trended credit data to offer a comprehensive view of borrower behavior."Our partnership with Pagaya represents a powerful
More news about: Achieve
Dec 17, 2025, 08:00 ET 2025 in Review: South Korea's Leading AI Innovator Marks Breakout Year After U.S. Launch
contact them here. Media ContactBlaire SwayzeDirector of InsurTech Comms & PRT Palmer [email protected]
More news about: Upstage AI
Dec 17, 2025, 07:30 ET Soligenix Announces Top-line Results of the Phase 2a Study of SGX302 (Synthetic Hypericin) in Patients with Mild-to-Moderate Psoriasis
of HyBryte™ in targeting malignant T-cells during cutaneous T-cell lymphoma (CTCL) clinical trials is a promising indicator of the ability of SGX302 to provide a much-needed approach for the treatment of mild-to-moderate psoriasis, also caused by dysregulated T-cells. We anticipate continuing to pursue
More news about: SOLIGENIX, INC.
Dec 17, 2025, 07:00 ET Creality Summit Brasil 2026 destaca a crescente demanda e a expansão do ecossistema de impressão 3D
a próxima geração da série K2, novas adições na impressão de resina com o Halot X1 e a estreia do scanner 3D Sermoon P1 e do gravador a laser Falcon T1. Juntos, esses produtos demonstraram a ampliação das ofertas da Creality para 2026, abrangendo usuários domésticos, prototipagem profissional e fluxos
More news about: Creality
Dec 17, 2025, 06:04 ET Power Transformers Market Outlook 2030: Growing at 6% CAGR Driven by Grid Modernization & Renewable Energy Integration; Asia-Pacific Leads, Reports Mordor Intelligence
Single-phaseThree-phaseBy End-UserPower utilities (renewables, non-renewables, and T&D)IndustrialCommercialResidentialBy RegionNorth America
More news about: Mordor Intelligence Private Limited
Dec 17, 2025, 00:39 ET WYBOT S3, 새로운 기준으로 수영장 로봇 산업 재정의...호주 출시 임박
있다.https://edge.prnewswire.com/c/link/?t=0&l=en&o=4581470-1&h=1224849858&u=https%3A%2F%2Fwww.au.wybotpool.com%2F&a=https%3A%2F%2Fwww.au.wybotpool.com%2F사진
More news about: WYBOTICS INC
Dec 16, 2025, 22:28 ET Roar through the Golden Dunes! JETOUR Global Fan Festival Launches Soon in Liwa
for enthusiasts, offering a gateway to freer, more expansive adventures.At the festival, JETOUR will showcase its models, including the G700 and T series, with exclusive test-drive opportunities. Attendees can experience the thrill of a 100-car desert parade, enjoy the co-create music performance,
More news about: JETOUR
Dec 16, 2025, 20:00 ET Antengene Expands XPOVIO® Indications in Malaysia with Approval in Diffuse Large B-cell Lymphoma
ATG-031 (CD24-targeting macrophage activator), and ATG-042 (oral PRMT5-MTA inhibitor).Antengene has also developed AnTenGager™, a proprietary T cell engager 2.0 platform featuring "2+1" bivalent binding for low-expressing targets, steric hindrance masking, and proprietary CD3 sequences with fast
More news about: Antengene Corporation Limited
Dec 16, 2025, 19:19 ET Allink Biotherapeutics completa rondas de extensión de la Serie A por 47 millones de dólares
plataforma tecnológica innovadoraMás allá de su tecnología ADC, AllinkBio está estableciendo una plataforma patentada de captadores de células T enmascarados (TCE) para desarrollar la aplicación de los TCE en tumores sólidos. En el ámbito de la inmunología, la compañía está desarrollando una cartera
More news about: Allink Biotherapeutics